상단영역
본문영역
Reporter’s Notebook 목록 ( 총 : 19 )
기사목록 보기 형태
-
[Reporter's Notebook] The abandoned Hanmi-OCI merger shows the power of the small shareholders
-
[Reporter's Notebook] Is lawmaker's claim that Celltrion's Covid-19 drug was a failure true?
-
[Reporter's Notebook] Korean companies bet on Cancer Moonshot but uncertainty looms
-
[Reporter's Notebook] GemVax & KAEL's 'miracle cure' for Alzheimer's disease needs scrutiny
-
[Reporter's Notebook] Is ‘special listing’ system hurting biotech industry?
-
[Reporter's notebook] Cheering for Lilly Korea’s bid
-
Mundipharma Korea, a ‘good place to work,’ suspends employees refusing ERP
-
[Reporter's Notebook] Lost are the government's bio-industry promotion policies for 2023
-
Korean biopharma shouldn’t make promises if they can’t keep them
-
Global Bio Conference, not ‘global’ at all
-
[Reporter’s Notebook] Why does Janssen need a PR department – or an offshoot -- in Korea?
-
[Reporter’s Notebook] Rival candidates ‘politicize’ foreign residents’ health insurance issue